The Inflation Reduction Act of 2022 (IRA) continues to reshape the Medicare Part D program through calendar years 2026 and 2027. While many provisions are designed to reduce costs for beneficiaries, they may also impact employer-sponsored prescription drug coverage. Key changes include the following:

The full content of this article is available to KTB Broker Partners via VOKA (login required).

LOGIN TO VOKA

Interested in learning more about the benefits of partnering with our agency? Visit our Contact page and a member of our Broker Relations team will reach out to set up a time to chat.

CONTACT US